DK1343777T3 - Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt - Google Patents

Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt

Info

Publication number
DK1343777T3
DK1343777T3 DK01270534T DK01270534T DK1343777T3 DK 1343777 T3 DK1343777 T3 DK 1343777T3 DK 01270534 T DK01270534 T DK 01270534T DK 01270534 T DK01270534 T DK 01270534T DK 1343777 T3 DK1343777 T3 DK 1343777T3
Authority
DK
Denmark
Prior art keywords
methanesulfonamido
preparation
synthetic intermediate
benzofuran derivative
benzofuran
Prior art date
Application number
DK01270534T
Other languages
English (en)
Inventor
Corinne Leroy
Noel Fino
Original Assignee
Sanofi Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo filed Critical Sanofi Synthelabo
Application granted granted Critical
Publication of DK1343777T3 publication Critical patent/DK1343777T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/80—Radicals substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Lubricants (AREA)
DK01270534T 2000-12-11 2001-12-10 Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt DK1343777T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0016070A FR2817864B1 (fr) 2000-12-11 2000-12-11 Derive de methanesulfonamido-benzofurane, son procede de preparation et son utilisation comme intermediaire de synthese

Publications (1)

Publication Number Publication Date
DK1343777T3 true DK1343777T3 (da) 2004-08-16

Family

ID=8857482

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01270534T DK1343777T3 (da) 2000-12-11 2001-12-10 Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt

Country Status (24)

Country Link
US (1) US6828448B2 (da)
EP (1) EP1343777B1 (da)
JP (1) JP4236926B2 (da)
CN (1) CN1229366C (da)
AR (1) AR032377A1 (da)
AT (1) ATE266016T1 (da)
AU (1) AU2002217226A1 (da)
BR (1) BR0116067B1 (da)
CA (1) CA2429422C (da)
CZ (1) CZ303488B6 (da)
DE (1) DE60103182T2 (da)
DK (1) DK1343777T3 (da)
ES (1) ES2220666T3 (da)
FR (1) FR2817864B1 (da)
HK (1) HK1055955A1 (da)
HR (1) HRP20030472B1 (da)
HU (1) HUP0500983A3 (da)
MX (1) MXPA03005222A (da)
PL (1) PL208122B1 (da)
PT (1) PT1343777E (da)
SI (1) SI1343777T1 (da)
SK (1) SK287280B6 (da)
TR (1) TR200401755T4 (da)
WO (1) WO2002048132A1 (da)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070148154A1 (en) * 2004-12-17 2007-06-28 Universite Rene Descartes (Paris V) Use of superoxide dismutase mimetics and reductase gultatione in the form of anticancer drugs
CN101153012B (zh) * 2006-09-29 2010-06-23 北京德众万全药物技术开发有限公司 一种决奈达隆关键中间体的新的制备方法
GB0719180D0 (en) * 2007-10-02 2007-11-14 Cambrex Karlskoga Ab New process
PE20091809A1 (es) 2008-04-17 2009-12-03 Sanofi Aventis Uso de dronedarona para la preparacion de un medicamento para uso en la prevencion de la hospitalizacion cardiovascular o de la mortalidad
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
BRPI1010300B8 (pt) * 2009-04-08 2021-05-25 Cambrex Karlskoga Ab processos para a preparação de um composto, de dronedarone, ou um sal do mesmo, de uma formulação farmacêutica, e de um intermediário de dronedarone, ou um sal do mesmo
CN101993427B (zh) * 2009-08-26 2012-10-10 成都伊诺达博医药科技有限公司 一种制备决奈达隆的方法
HUP0900759A2 (en) 2009-12-08 2011-11-28 Sanofi Aventis Novel process for producing dronedarone
HUP1000010A2 (en) 2010-01-08 2011-11-28 Sanofi Sa Process for producing dronedarone
FR2957079B1 (fr) 2010-03-02 2012-07-27 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
EP2371808A1 (en) 2010-03-08 2011-10-05 Ratiopharm GmbH Process for preparing dronedarone
EP2371824A1 (en) 2010-03-08 2011-10-05 Ratiopharm GmbH Crystalline dronedarone salts
FR2958290B1 (fr) * 2010-03-30 2012-10-19 Sanofi Aventis Procede de preparation de derives de sulfonamido-benzofurane
FR2958289B1 (fr) * 2010-03-30 2012-06-15 Sanofi Aventis Procede de preparation de derives de 3-ceto-benzofurane
FR2958291B1 (fr) 2010-04-01 2013-07-05 Sanofi Aventis Procede de preparation de derives d'amino-benzofurane
CN101838252B (zh) * 2010-05-27 2016-05-04 北京德众万全医药科技有限公司 2-正丁基-5-取代氨基苯并呋喃及其制备方法
HUP1000330A2 (en) 2010-06-18 2011-12-28 Sanofi Sa Process for the preparation of dronedarone and the novel intermediates
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2012004658A2 (en) * 2010-07-09 2012-01-12 Frichem Private Limited Process for preparation of n-[2-butyl-3-[4-[3-(dibutylamino)propoxy]benzoyl]-5-benzofuranyl]methanesulfonamide, acid addition salts and product thereof
FR2962731B1 (fr) * 2010-07-19 2012-08-17 Sanofi Aventis Procede de preparation de derives d'amino-benzoyl-benzofurane
FR2963006B1 (fr) 2010-07-21 2013-03-15 Sanofi Aventis Procede de preparation de derives de nitro-benzofurane
HUP1000386A2 (en) 2010-07-22 2012-05-29 Sanofi Sa Novel process for producing dronedarone
WO2012032545A1 (en) 2010-09-08 2012-03-15 Cadila Healthcare Limited Processes for preparing dronedarone and its intermediates
EP2452938A1 (en) 2010-11-12 2012-05-16 LEK Pharmaceuticals d.d. Process for the preparation of 3-aroyl-5-aminobenzofuran derivatives
WO2012120544A2 (en) 2011-03-10 2012-09-13 Sun Pharmaceutical Industries Ltd. PROCESS FOR N-[2-n-BUTYL-3-[4-[3-(DI-n-BUTYLAMINO) PROPOXY]ENZOYL]BENZOFURAN-5-YL]METHANESULFONAMIDE HYDROCHLORIDE
FR2973027A1 (fr) * 2011-03-24 2012-09-28 Sanofi Aventis Procede de synthese de derives de cetobenzofurane
HUP1100166A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Reductive amination process for preparation of dronedarone using amine intermediary compound
HUP1100167A2 (en) 2011-03-29 2012-11-28 Sanofi Sa Process for preparation of dronedarone by mesylation
HUP1100165A2 (en) 2011-03-29 2012-12-28 Sanofi Sa Process for preparation of dronedarone by n-butylation
CN102321057A (zh) * 2011-06-02 2012-01-18 北京阳光诺和药物研究有限公司 N-取代的甲磺酰基胺基-苯并呋喃衍生物、其制备方法及用途
WO2013014478A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive amination process for preparation of dronedarone using carboxyl intermediary compound
WO2013014480A1 (en) 2011-07-26 2013-01-31 Sanofi Process for preparation of dronedarone using amide intermediary compound
WO2013014479A1 (en) 2011-07-26 2013-01-31 Sanofi Reductive animation process for preparation of dronedarone using aldehyde intermediary compound
FR2983198B1 (fr) 2011-11-29 2013-11-15 Sanofi Sa Procede de preparation de derives de 5-amino-benzoyl-benzofurane
EP2617718A1 (en) 2012-01-20 2013-07-24 Sanofi Process for preparation of dronedarone by the use of dibutylaminopropanol reagent
WO2013121235A2 (en) 2012-02-13 2013-08-22 Sanofi Process for preparation of dronedarone by removal of hydroxyl group
US9249119B2 (en) 2012-02-14 2016-02-02 Sanofi Process for the preparation of dronedarone by oxidation of a sulphenyl group
WO2013124745A1 (en) 2012-02-22 2013-08-29 Sanofi Process for preparation of dronedarone by oxidation of a hydroxyl group
WO2013178337A1 (en) * 2012-05-31 2013-12-05 Sanofi Process for preparation of dronedarone by grignard reaction
TW201536763A (zh) * 2013-08-27 2015-10-01 Gilead Sciences Inc 製備決奈達隆或其鹽類之製程
CN103450124B (zh) * 2013-08-30 2016-03-09 江苏九九久科技股份有限公司 决奈达隆合成方法
CN104892553B (zh) * 2015-04-27 2017-06-20 惠州信立泰药业有限公司 一种盐酸决奈达隆的晶体及其制备方法和含有该晶体的药物组合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2665444B1 (fr) * 1990-08-06 1992-11-27 Sanofi Sa Derives d'amino-benzofuranne, benzothiophene ou indole, leur procede de preparation ainsi que les compositions les contenant.
GB9416219D0 (en) * 1994-08-11 1994-10-05 Karobio Ab Receptor ligands

Also Published As

Publication number Publication date
FR2817864A1 (fr) 2002-06-14
CA2429422A1 (fr) 2002-06-20
MXPA03005222A (es) 2004-03-26
US6828448B2 (en) 2004-12-07
BR0116067A (pt) 2003-10-28
HUP0500983A2 (en) 2006-03-28
EP1343777A1 (fr) 2003-09-17
SK7282003A3 (en) 2003-10-07
FR2817864B1 (fr) 2003-02-21
US20040048921A1 (en) 2004-03-11
HRP20030472A2 (en) 2005-04-30
HRP20030472B1 (en) 2006-02-28
ES2220666T3 (es) 2004-12-16
BR0116067B1 (pt) 2014-04-08
CN1479735A (zh) 2004-03-03
EP1343777B1 (fr) 2004-05-06
SK287280B6 (sk) 2010-05-07
CN1229366C (zh) 2005-11-30
AR032377A1 (es) 2003-11-05
HK1055955A1 (en) 2004-01-30
CZ20031610A3 (cs) 2003-08-13
PL364767A1 (en) 2004-12-13
DE60103182D1 (de) 2004-06-09
CA2429422C (fr) 2010-09-28
TR200401755T4 (tr) 2004-08-23
PT1343777E (pt) 2004-08-31
JP2004526681A (ja) 2004-09-02
DE60103182T2 (de) 2005-05-04
JP4236926B2 (ja) 2009-03-11
ATE266016T1 (de) 2004-05-15
PL208122B1 (pl) 2011-03-31
SI1343777T1 (en) 2004-10-31
WO2002048132A1 (fr) 2002-06-20
AU2002217226A1 (en) 2002-06-24
HUP0500983A3 (en) 2012-09-28
CZ303488B6 (cs) 2012-10-17

Similar Documents

Publication Publication Date Title
DK1343777T3 (da) Methansulfonamido-benzofuranderivat, fremgangsmåde til dets fremstilling og dets anvendelse som syntesemellemprodukt
NO20025879D0 (no) Acylfenylureaderivater, fremgangsmåte for fremstilling derav og deres anvendelse som et legemiddel
BR0106100B1 (pt) composição de gesso fixado, artigo, e, método para preparar uma composição de gesso fixado.
DK1425014T3 (da) Diarylcycloalkylderivater, fremgangsmåde til deres fremstilling og deres anvendelse som PPAR-aktivatorer
DK1381605T3 (da) Mercaptoacetylamidderivater, en fremgangsmåde til deres fremstilling og deres anvendelse
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
DK1180518T3 (da) 5-pyridyl-1,3-azolforbindelser, fremgangsmåde til fremstilling deraf og anvendelse deraf
DK1218341T3 (da) Sulfonylcarboxamid-derivater, fremgangsmåde til deres fremstilling og deres anvendelse som lægemiddel
NO20033726L (no) Xantin-derivater, fremstilling og anvendelse derav som et medikament
DK1317431T3 (da) Polyarylcarboxamider, der er anvendelige som lipidsænkende midler
EE200200704A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200200470A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
EE200300245A (et) Bensotiofeeni derivaadid, nende valmistamise meetod ja kasutamine
DK1453810T3 (da) Substituerede 4-phenyltetrahydroisoquinoliner, fremgangsmåde til deres fremstilling, deres anvendelse som medikament indeholdende samme
DK1322158T3 (da) Farmaceutiske præparater med langvarig frigivelse, som indeholder metformin, og fremgangsmåde til fremstilling deraf
DK1339685T3 (da) Biphenylcarboxamider, der er egnede som lipidsænkende midler
NO20026128D0 (no) Gelformet drivstoff, fremgangsmåte for dets fremstilling og dets anvendelse
NO20010219L (no) Polycykliske tiazolidin-2-ylidenaminer, fremgangsmÕte for deres fremstilling og deres anvendelse som legemiddel
EE200200697A (et) Uued ühendid, meetod nende valmistamiseks ning nende kasutamine
DK1053224T3 (da) Biphenylfulfonylcyanamider, fremgangsmåde til fremstilling deraf og anvendelse deraf som lægemiddel
DK1261625T3 (da) Memnopeptider, en fremgangsmåde til deres fremstilling og deres anvendelse
DK1257527T3 (da) (2S)-Aminoindanderivater, en fremgangsmåde til deres præparation og deres anvendelse som selektive dopamin-D3-ligander
DK1157020T3 (da) Substituerede 1,2,3,4,5,6-hexahydro-2,6-methano-2-benzazocin-10-oler, fremgangsmåder til deres fremstilling og deres anvendelse som lægemiddel
MXPA03000975A (es) Composicion farmaceutica.
DK1265873T3 (da) 4-Oxo-1,4-dihydro-3-cinnolincarboxamider som antivirale midler